Meditech cautions investors on stock volatility, Huawei, DeepSeek

Suzhou MedicalSystem Technology (SSE:603990) has issued a statement addressing recent abnormal fluctuations in its stock trading, triggered by a cumulative closing price deviation exceeding 20% over three consecutive trading days (February 13, 14, and 17). The company confirms no undisclosed material information exists after internal verification and inquiries with its controlling shareholder. Meditech acknowledged market interest in its collaborations with Huawei, clarifying that current partnerships involve adapting software for Huawei's hardware, operating systems, and databases, projects yet to generate revenue. Joint projects are also underway. The company stated that it has not signed formal agreements with Huawei for its Ascend-related services, leading to business development uncertainty. The company said it integrated the open-source DeepSeek model, but has no formal collaboration with the DeepSeek company. The company urges investors to exercise caution and be aware of secondary market trading risks, stating operations remain normal and citing the absence of major adjustments to its internal or external operating environment.